Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Peter Ljubenkov, Md

Clinical trials sponsored by Peter Ljubenkov, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a pill slow a rare dementia? early trial begins Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Could a pill slow a rare dementia? early trial begins

Disease control Ongoing

This early-stage trial tests an oral drug called verdiperstat in 64 people with semantic variant primary progressive aphasia (svPPA), a rare dementia that affects language. The study is double-blind and placebo-controlled, meaning some participants get the drug and some get a pla…

Phase 1 • Sponsor: Peter Ljubenkov, MD • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC